Associations of the KiSS-1 and GPR54 genetic polymorphism with polycystic ovary syndrome in Yunnan, China

References

• Wolf WM, Wattick RA, Kinkade ON, et al. Geographical prevalence of polycystic ovary syndrome as determined by region and race/ethnicity. Int J Environ Res Public Health. 2018;15:1–13.
   Web of Science ®Google Scholar
• Wijeyaratne CN, Dilini Udayangani SA, Balen AH. Ethnic-specific polycystic ovary syndrome: epidemiology, significance and implications. Expert Rev Endocrinol Metab. 2013;8(1):71–79.
   PubMedGoogle Scholar
• March WA, Moore VM, Willson KJ, et al. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. 2010;25(2):544–551.
   PubMed Web of Science ®Google Scholar
• Patel S. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy. J Steroid Biochem Mol Biol. 2018;182:27–36.
   PubMed Web of Science ®Google Scholar
• Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81:19–25. [Database][Mismatch
   Web of Science ®Google Scholar
• Goodarzi Mea. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol. 2011;7:219–231.
   PubMed Web of Science ®Google Scholar
• Franks S, McCarthy MI, Hardy K. Development of polycystic ovary syndrome: involvement of genetic and environmental factors. Int J Androl. 2006;29(1):278–285.
   PubMedGoogle Scholar
• Varikasuvu SR, Prasad VS, Vamshika VC, et al. Circulatory metastin/kisspeptin-1 in polycystic ovary syndrome: a systematic review and Meta-analysis with diagnostic test accuracy. Reprod Biomed Online. 2019;39(4):685–697.
   PubMed Web of Science ®Google Scholar
• Rashad NM, Al-Sayed RM, Yousef MS, et al. Kisspeptin and body weight homeostasis in relation to phenotypic features of polycystic ovary syndrome; metabolic regulation of reproduction. Diabetes Metab Syndr. 2019;13(3):2086–2092.
   PubMed Web of Science ®Google Scholar
• Ibrahim RO, Omer SH, Fattah CN. The correlation between hormonal disturbance in PCOS women and serum level of kisspeptin. Int J Endocrinol. 2020;2020:1–8.
   Web of Science ®Google Scholar
• Araújo BS, Baracat MCP, Dos Santos Simões R, et al. Kisspeptin influence on polycystic ovary syndrome-a mini review. Reprod Sci. 2020;27(2):455–460.
   PubMed Web of Science ®Google Scholar
• Branavan U, Wijesundera S, Chandrasekaran V, et al. In depth analysis of the association of FTO SNP (rs9939609) with the expression of classical phenotype of PCOS: a Sri Lankan study. BMC Med Genet. 2020;21(1):30–30.
   PubMed Web of Science ®Google Scholar
• Daghestani MH, Daghestani MH, Daghistani M, et al. Relevance of KISS1 gene polymorphisms in susceptibility to polycystic ovary syndrome and its associated endocrine and metabolic disturbances. Br J Biomed Sci. 2020;77(4):185–190.
   PubMed Web of Science ®Google Scholar
• Zeydabadi Nejad S, Ramezani Tehrani F, Zadeh-Vakili A. The role of kisspeptin in female reproduction. Int J Endocrinol Metab. 2017;15(3):e44337.
   PubMed Web of Science ®Google Scholar
• Branavan U, Muneeswaran K, Wijesundera WSS, et al. Association of Kiss1 and GPR54 gene polymorphisms with polycystic ovary syndrome among Sri Lankan women. Biomed Res Int. 2019;2019:1–10.
   Web of Science ®Google Scholar
• de Roux N, Genin E, Carel JC, et al. Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc Natl Acad Sci U S A. 2003;100(19):10972–10976.
   PubMed Web of Science ®Google Scholar
• Seminara SB, Messager S, Chatzidaki EE, et al. The GPR54 gene as a regulator of puberty. N Engl J Med. 2003;349(17):1614–1627.
   PubMed Web of Science ®Google Scholar
• Gorkem U, Togrul C, Arslan E, et al. Is there a role for kisspeptin in pathogenesis of polycystic ovary syndrome? Gynecol Endocrinol. 2018;34(2):157–160.
   PubMed Web of Science ®Google Scholar
• Jeon YE, Lee KE, Jung JA, et al. Kisspeptin, leptin, and retinol-binding protein 4 in women with polycystic ovary syndrome. Gynecol Obstet Invest. 2013;75(4):268–274.
   PubMed Web of Science ®Google Scholar
• Albalawi FS, Daghestani MH, Daghestani MH, et al. rs4889 polymorphism in KISS1 gene, its effect on polycystic ovary syndrome development and anthropometric and hormonal parameters in saudi women. J Biomed Sci. 2018;25(1):50.
   PubMedGoogle Scholar
• Esparza LA, Schafer D, Ho BS, et al. Hyperactive LH pulses and elevated kisspeptin and NKB gene expression in the arcuate nucleus of a PCOS mouse model. Endocrinology. 2020;161(4):bqaa018.
   PubMed Web of Science ®Google Scholar
• Wang T, Han S, Tian W, et al. Effects of kisspeptin on pathogenesis and energy metabolism in polycystic ovarian syndrome (PCOS). Gynecol Endocrinol. 2019;35(9):807–810.
   PubMed Web of Science ®Google Scholar
• Meczekalski B, Katulski K, Podfigurna-Stopa A, et al. Spontaneous endogenous pulsatile release of kisspeptin is temporally coupled with luteinizing hormone in healthy women. Fertil Steril. 2016;105(5):1345–1350.
   PubMed Web of Science ®Google Scholar
• Katulski K, Podfigurna A, Czyzyk A, et al. Kisspeptin and LH pulsatile temporal coupling in PCOS patients. Endocrine. 2018;61(1):149–157.
   PubMed Web of Science ®Google Scholar
• Daghestani MH, Daghestani MH, Daghistani M, et al. Influence of KISS1 gene polymorphisms on the risk of polycystic ovary syndrome and its associated variables, in saudi women. BMC Endocr Disord. 2020;20(1):59.
   PubMed Web of Science ®Google Scholar
• Codner E, Iñíguez G, Villarroe C, et al. Hormonal profile in women with polycystic ovarian syndrome with or without type 1 diabetes mellitus. J Clin Endocrinol Metab. 2007;92(12):4742–4746.
   PubMed Web of Science ®Google Scholar
• Gottsch ML, Cunningham MJ, Smith JT, et al. A role for kisspeptins in the regulation of gonadotropin secretion in the mouse. Endocrinology. 2004;145(9):4073–40777.
   PubMed Web of Science ®Google Scholar
• Navarro VM, Castellano JM, Fernandez-Fernandez R, et al. Characterization of the potent LH releasing activity of KiSS-1 peptide, the natural ligand of GPR54. Endocrinology. 2005;146(1):156–163.
   PubMed Web of Science ®Google Scholar
• Xiao ZN, Peng JL, Yang J, et al. Flexible GnRH antagonist protocol versus progestin-primed ovarian stimulation (PPOS) protocol in patients with polycystic ovary syndrome: Comparison of clinical outcomes and ovarian response. Curr Med Sci. 2019;39(3):431–436.
   PubMed Web of Science ®Google Scholar
• Vrtacnik-Bokal E, Virant Klun I, Verdenik I. Follicular oestradiol and VEGF after GnRH antagonists or GnRH agonists in women with PCOS. Reprod Biomed Online. 2009;18(1):21–28.36.
   PubMed Web of Science ®Google Scholar
• Ajmal N, Khan SZ, Shaikh R. Polycystic ovary syndrome (PCOS) and genetic predisposition: a review article. Eur J Obstet Gynecol Reprod Biol X. 2019;8:3:100060.
   Google Scholar
• Kim JJ, Choi YM. Phenotype and genotype of polycystic ovary syndrome in asia: Ethnic differences. J Obstet Gynaecol Res. 2019;45(12):2330–2337.
   PubMed Web of Science ®Google Scholar
• Huang Z, Yong EL. Ethnic differences: is there an asian phenotype for polycystic ovarian syndrome? Best Pract Res Clin Obstet Gynaecol. 2016;37:46–55.
   PubMed Web of Science ®Google Scholar